Literature DB >> 27027985

Multidetector computed tomography features of pancreatic metastases from leiomyosarcoma: Experience at a tertiary cancer center.

Chong Hyun Suh1, Abhishek Keraliya1, Atul B Shinagare1, Kyung Won Kim1, Nikhil H Ramaiya1, Sree Harsha Tirumani1.   

Abstract

AIM: To describe the multidetector computed tomography features of pancreatic metastasis from leiomyosarcoma (LMS).
METHODS: Between January 1995 and December 2012, 13 consecutive patients (11 women, 2 men; mean age of 57 years; range, 38-78 years) with pancreatic metastases from LMS were included in our study. Imaging features including location, number, largest dimension, tumor attenuation and enhancement characteristics, presence of necrosis, pancreatic ductal dilatation, common bile duct (CBD) dilatation, presence of pancreatitis, and atrophy were documented.
RESULTS: The most common site of origin of the pancreatic metastases from LMS was uterus (38.5%), followed by retroperitoneum (30.8%) and extremity (23.1%). None of the patients in our study had pancreas as the first site of metastasis. All patients developed pancreatic metastases at a median interval of 24 mo. Pancreatic metastases from LMS were solitary in 8/13 patients and multiple in 5/13 patients, had no predilection for any part of the pancreas, were hypovascular on arterial phase in 10/13 patients and associated with pancreatic duct dilatation in 3/13 patients. None had CBD dilatation. None of the pancreatic metastases in LMS cohort caused pancreatitis, and atrophy. Median duration of follow-up was 19 mo for LMS cohort during which two patients underwent resection of metastasis (median survival 45 mo) while the remaining underwent systemic therapy (median survival 13 mo).
CONCLUSION: Pancreatic metastases from LMS are often solitary and hypovascular masses and less commonly associated with pancreatic ductal dilatation, CBD dilatation, pancreatitis or pancreatic atrophy. Surgical resection of solitary LMS pancreatic metastasis can be considered due to the long survival of these patients.

Entities:  

Keywords:  Hypovascular; Leiomyosarcoma; Multidetector computed tomography; Pancreatic metastasis; Renal cell carcinoma

Year:  2016        PMID: 27027985      PMCID: PMC4807341          DOI: 10.4329/wjr.v8.i3.316

Source DB:  PubMed          Journal:  World J Radiol        ISSN: 1949-8470


  19 in total

Review 1.  Uterine sarcomas: then and now.

Authors:  Shaan H Shah; Jyothi P Jagannathan; Katherine Krajewski; Kevin N O'Regan; Suzanne George; Nikhil H Ramaiya
Journal:  AJR Am J Roentgenol       Date:  2012-07       Impact factor: 3.959

2.  Patterns of metastasis in uterine sarcoma. An autopsy study.

Authors:  P G Rose; M S Piver; Y Tsukada; T Lau
Journal:  Cancer       Date:  1989-03-01       Impact factor: 6.860

Review 3.  Uterine leiomyosarcoma metastasis to the pancreas: report of a case and review of the literature.

Authors:  Jaime Alonso Gómez; Álvaro Arjona Sánchez; David Martínez Cecilia; Rafael Díaz Nieto; Jorge Roldán de la Rúa; Amparo Valverde Martínez; Enrique Lizárraga Febres; Javier Padillo Ruiz; Sebastián Rufián Peña
Journal:  J Gastrointest Cancer       Date:  2012-06

4.  Renal cell carcinoma metastatic to the pancreas: results of surgical management.

Authors:  T A Sohn; C J Yeo; J L Cameron; A Nakeeb; K D Lillemoe
Journal:  J Gastrointest Surg       Date:  2001 Jul-Aug       Impact factor: 3.452

Review 5.  Renal cancer cell metastasis into the pancreas: a single-center experience and overview of the literature.

Authors:  Moritz N Wente; Jörg Kleeff; Irene Esposito; Mark Hartel; Michael W Müller; Boris E Fröhlich; Markus W Büchler; Helmut Friess
Journal:  Pancreas       Date:  2005-04       Impact factor: 3.327

6.  Pancreaticoduodenectomy for metastasis of uterine leiomyosarcoma to the pancreas.

Authors:  Sara Hernández; José Martín-Fernández; Inmaculada Lasa; Ignacio Busteros; Francisca García-Moreno
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

7.  Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy.

Authors:  Markus W Büchler; Markus Wagner; Bruno M Schmied; Waldemar Uhl; Helmut Friess; Kaspar Z'graggen
Journal:  Arch Surg       Date:  2003-12

8.  Multiple hypervascular pancreatic metastases from renal cell carcinoma: dynamic MR and spiral CT in three cases.

Authors:  Giorgio Ascenti; Carmela Visalli; Antonino Genitori; Antonio Certo; Alessia Pitrone; Silvio Mazziotti
Journal:  Clin Imaging       Date:  2004 Sep-Oct       Impact factor: 1.605

9.  Metastasis to the pancreas: characterization by morphology and contrast enhancement features on CT and MRI.

Authors:  Moritz Palmowski; Nicola Hacke; Stefanie Satzl; Miriam Klauss; Moritz N Wente; Martin Neukamm; Joerg Kleeff; Peter Hallscheidt
Journal:  Pancreatology       Date:  2008-04-23       Impact factor: 3.996

Review 10.  The consensus statement on the locoregional treatment of abdominal sarcomatosis.

Authors:  Carlo Riccardo Rossi; Paolo Casali; Shigeki Kusamura; Dario Baratti; Marcello Deraco
Journal:  J Surg Oncol       Date:  2008-09-15       Impact factor: 3.454

View more
  4 in total

Review 1.  Primary Leiomyosarcoma of the Pancreas-a Case Report and a Comprehensive Review.

Authors:  Jon Arne Søreide; Erling Sandøy Undersrud; Mohammed S S Al-Saiddi; Tore Tholfsen; Kjetil Søreide
Journal:  J Gastrointest Cancer       Date:  2016-12

2.  Disseminated and late metastatic disease from nasal pit leiomyosarcoma after radical surgical resection. Case report of a singular presentation of a rare disease.

Authors:  Enrico Pinotti; Marta Sandini; Simone Famularo; Marta Jaconi; Fabrizio Romano; Luca Nespoli; Luca Gianotti
Journal:  Clin Sarcoma Res       Date:  2017-06-06

3.  Recurrent broad ligament leiomyosarcoma with pancreatic and thigh metastasis: a case report.

Authors:  Xuan Tian; Xin Yan; Jun Wu; Hongli Song; Zhongyang Shen
Journal:  BMC Surg       Date:  2020-06-29       Impact factor: 2.102

Review 4.  Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer.

Authors:  Takeshi Okamoto
Journal:  World J Gastroenterol       Date:  2022-03-14       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.